PROM1 and brain neoplasm: Although CSCs may represent a heterogeneous population, the glycoprotein prominin 1/CD133, an important marker of adult stem cells and CSCs, has been used for the isolation of several types of tumorigenic cells from brain tumors, as well as kidney, hepatocellular, colon, pancreatic and prostate carcinomas [2,3,7].